IP Verse

Improved Protocol For Treatment Of Lupus Nephritis

Patent No. EP3634463 (titled "Improved Protocol For Treatment Of Lupus Nephritis") was filed by Aurinia Pharmaceuticals on May 11, 2018. The application was issued on Jan 10, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALENICUM HEALTH SLUJun 27, 2024GALENICUM HEALTH SLU
BOTTI & FERRARIJun 26, 2024BOTTI & FERRARI
HAMM & WITTKOPPJun 26, 2024HAMM & WITTKOPP
MAIWALDJun 26, 2024MAIWALD
TEVA PHARMACEUTICALSJun 26, 2024KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3634463

AURINIA PHARMACEUTICALS
Application Number
EP18798594A
Filing Date
May 11, 2018
Status
Granted And Under Opposition
Aug 25, 2023
Publication Date
Jan 10, 2024
External Links
Slate, Register , Google Patents